Endometriosis Trial, Recruiting NCT06955221 Sponsor: Hospital Universitari de Bellvitge Condition: Endometriosis
Back to Endometriosis

Endometriosis Trial, Recruiting

NCT06955221
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are female and between 18 and 45 years old
  • An ultrasound scan has suggested you have a single-chamber ovarian cyst (endometrioma), or one with only a very thin internal wall (less than 3mm)
  • The cyst is between 30mm and 100mm in size and has been present for at least 3 to 6 months since it was first found
  • Your blood test results show certain markers (Ca125 and HE4) are within specific low ranges, suggesting the cyst is unlikely to be cancerous (confirm with trial site)
  • You have read and signed a consent form agreeing to take part

Who may not be able to join:

  • You are younger than 18 or older than 45 years old
  • You have a history of ovarian or uterine cancer
  • Your cyst is smaller than 30mm or larger than 100mm
  • Your doctor has recommended surgery for the cyst, for example due to severe endometriosis outside the ovary or another medical reason
  • Your ultrasound suggests the cyst may be a different type, such as a dermoid cyst or a cyst that could be cancerous
  • Your Ca125 blood marker result is above 300 UI/mL
  • Your HE4 blood marker result is above 70 pM
  • You are currently pregnant
  • You do not wish to take part, or you are not able to give informed consent for any reason

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Amparo Garcia-Tejedor, MDPhD, Hospital Universitari de Bellvitge

Phone: 34 + 932607695

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Hospital Universitari de Bellvitge
Registry
ClinicalTrials.gov
Start date
1 January 2025
Est. completion
31 December 2026

Where this trial is recruiting

🇪🇸 Spain

Primary endpoints

Quality of Life of patients with endometrioma

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov